Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Dr Reddy’s Laboratories ( (RDY) ) has shared an update.
On February 4, 2025, Dr. Reddy’s Laboratories announced its participation in an investor conference scheduled for February 11, 2025, organized by Nuvama in Mumbai. The conference will involve in-person meetings with investor groups, potentially impacting the company’s investor relations and market position in the pharmaceutical industry.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a pharmaceutical company based in Hyderabad, India. It focuses on providing a wide range of generic medications and active pharmaceutical ingredients (APIs) across various global markets.
YTD Price Performance: -11.81%
Average Trading Volume: 1,574,767
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.73B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
